Zoetis Inc.’s Stock Price Drops to $164.93, Reflecting a 5.15% Decline: A Closer Look at the Performance

Zoetis Inc. (ZTS)

164.93 USD -8.95 (-5.15%) Volume: 12.18M

Zoetis Inc.’s stock price currently stands at 164.93 USD, experiencing a significant drop of -5.15% this trading session with a high trading volume of 12.18M. Despite this fluctuation, the year-to-date (YTD) percentage change maintains a steady rate of -0.00%, indicating a stable stock performance for ZTS.

Latest developments on Zoetis Inc.

Zoetis (NYSE:ZTS) recently reported fourth-quarter sales in line with estimates, but the stock experienced a drop as its 2025 guidance fell short of expectations. Despite expanding its cattle anti-infective product line and receiving accolades such as the 2024 Zoetis Research Excellence Award, the company’s stock price took a hit following the release of its earnings report. While Zoetis exceeded revenue forecasts and beat analysts’ earnings estimates, the 2025 adjusted EPS guidance of $6.00-$6.10 fell below the consensus of $6.30, leading to a 10.6% drop in stock price. Investors are closely monitoring Zoetis as it navigates these challenges and implements new strategies to drive growth.

A look at Zoetis Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Zoetis has a promising long-term outlook. With a strong momentum score of 4, the company is showing positive growth potential and market performance. Additionally, Zoetis scores well in the dividend and growth categories, indicating stability and room for expansion in the future. While the value and resilience scores are not as high, the overall outlook for Zoetis remains optimistic.

Zoetis Inc. is a global leader in animal health medicines and vaccines, catering to both livestock and companion animals. With a presence in multiple continents, including North America, Europe, Africa, Asia, Australia, and Latin America, the company has a wide reach and solid foundation for continued growth. The Smartkarma Smart Scores highlight Zoetis’ strengths in momentum, dividend, and growth, pointing towards a bright future for the company in the animal health industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma